Veeva Systems (VEEV) Baird 2024 Global Consumer, Technology & Services Conference summary

Strategic vision and market opportunity

• Building an industry cloud for life sciences, offering software, data, and consulting tailored to the sector.

• Operates across R&D and commercial segments with five major product categories in each.

• Total addressable market (TAM) has grown from $2B at IPO to $20B, reflecting new products and future opportunities.

• Aims to capture about 1% of the $2T life sciences market, focusing on long-term, durable growth.

• Platform approach increases value for customers as they adopt more products.

Customer base and growth dynamics

• Top 20 pharma companies represent a significant revenue concentration, but there is a long tail of smaller and pre-commercial companies.

• Average customer uses four commercial and three R&D products, out of over 30 available.

• Growth potential remains in both large and smaller customers, though smaller ones may not reach top-tier spend levels.

• Product adoption is modular, with multiple entry points and expansion paths.

• Longer time in market correlates with higher product adoption rates.

Financial outlook and innovation

• Billings are projected to grow 10% this year, with software outpacing services.

• Long-term growth is supported by a large market, strong competitive positioning, and ongoing innovation.

• Market opportunity and growth path may fluctuate quarter to quarter, but the long-term outlook is positive.